SECOND LINE ERLOTINIB IN NON-SMALL CELL LUNG CANCER: A LOCAL EXPERIENCE

被引：0
|
作者：
Smith, C. F. [1 ]
Garcia-Alonso, Angel [1 ]
Drury, G. [1 ]
Gostage, A. [1 ]
Smith, N. [1 ]
机构：
[1] Betsi Cadwaladr Univ Hlth Board, N Wales Canc Treatment Ctr, Bangor, Gwynedd, Wales
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
erlotinib; second line; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S1180 / S1181
页数：2
相关论文
共 50 条
  • [1] Experience with erlotinib in the treatment of non-small cell lung cancer
    Landi, Lorenza
    Cappuzzo, Federico
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (04) : 146 - 163
  • [2] CHEMOTHERAPY VERSUS ERLOTINIB IN THE SECOND LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER
    Fiala, Ondrej
    Pesek, Milos
    Krejci, Jana
    Sticha, Michal
    Minarik, Marek
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1259 - S1260
  • [3] ERLOTINIB in Second Line Treatment of Metastatic Lung Cancer: About 20 Case of Non-Small Cell LUNG
    Teyar, Nahla
    Bensaou, Malika Gamaz
    Bouzid, Kamel
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1498 - S1499
  • [4] Second-line erlotinib for non-small-cell lung cancer
    Lorusso, Vito
    Cinieri, Saverio
    LANCET ONCOLOGY, 2012, 13 (04): : E141 - E142
  • [5] Pemetrexed in second line treatment of non-small cell lung cancer - The Portuguese experience
    Araujo, A.
    Barata, F.
    Parente, B.
    Rego, S.
    Teixeira, E.
    Melo, M.
    Queiroga, H.
    Cunha, J.
    Duarte, J.
    Coelho, A.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2008, 14 : S9 - S20
  • [6] Pemetrexed in second line of non-small cell lung cancer
    Earata, Fernando
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2008, 14 : S21 - S26
  • [7] Pharmacoeconomic analysis of erlotinib as second-line treatment of advanced non-small cell lung cancer in Taiwan
    Hsia, T.
    Chang, G.
    Chen, Y.
    Lin, M.
    Su, W.
    Tsai, C.
    Tsai, C.
    Yang, L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 375 - 375
  • [8] Erlotinib in non-small cell lung cancer: a review
    Blackhall, FH
    Rehman, S
    Thatcher, N
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 995 - 1002
  • [9] Erlotinib in the treatment of non-small cell lung cancer
    Brown, Ewan R.
    Shepherd, Frances A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (05) : 767 - 775
  • [10] Erlotinib in non-small lung cancer: a single institution experience
    Rizvi, S. A. J.
    Eldeeb, H.
    LUNG CANCER, 2018, 115 : S32 - S32
12345